The 2025 Wondfo Global Partners Conference & POCT Summit recently concluded successfully in Dubai, bringing together over 200 global partners, industry experts, and key opinion leaders. This premier event fostered collaboration on cutting-edge technologies and trends in POCT and pathology, driving sustainable industry growth and accelerating the global adoption of innovative diagnostic solutions to safeguard public health.
 
 

Sharing Global Industry Insights & Shaping the Future of Diagnostics

Under the theme "Vision in One, Values for All," Wondfo invited international experts and representatives from leading hospitals and laboratories worldwide to foster industry exchange. Discussions centered on leveraging technological innovation to enhance diagnostic efficiency, reduce healthcare costs, and improve patient accessibility. Through keynote presentations and academic discussions, attendees gained invaluable insights into the future of medical diagnostics.
 

The conference featured keynote experts Prof. Khosrow Adeli – Ex-President of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) and Head & Professor of Pediatric Laboratory Medicine, The Hospital for Sick Children (SickKids), University of Toronto; Prof. Sergio Bernardini – Secretary General of the IFCC and Professor of Clinical Biochemistry, University of Rome Tor Vergata; and Prof. Damien Gruson – Head of the Department of Clinical Biochemistry of the Cliniques Universitaires Saint Luc, Chair of the Division on Emerging Technology of the IFCC. These experts shared groundbreaking insights into POCT development and applications, emphasizing how point-of-care testing is revolutionizing diagnostic accuracy, efficiency, and accessibility in global healthcare systems.
 
A roundtable discussion followed, featuring distinguished experts from leading hospitals and laboratories. Panelists explored the role of POCT in primary healthcare, emergency and critical care, chronic disease management, and infectious disease diagnostics. They also shared real-world case studies from different regions, providing attendees with valuable industry perspectives.


Innovative Launches Driving Global Healthcare Advancements
 
During his presentation, Wondfo’s Vice President, Mark Xu, reaffirmed the company’s unwavering commitment to its mission—continuously identifying healthcare needs, driving research and innovation, and delivering stable, accurate, and user-friendly in vitro diagnostic (IVD) solutions. With a focus on faster, earlier, and closer-to-patient diagnosis, Wondfo strives to make quality healthcare more accessible worldwide.
 

Wondfo also unveiled its latest diagnostic innovations and global market strategy, introducing cutting-edge solutions across primary care, emergency & critical care, and pathology. These high-precision, rapid testing technologies aim to improve diagnostic efficiency and transform healthcare delivery worldwide.

 
Primary Care Solutions
 
Leveraging fluorescence immunoassay, chemiluminescence, electrochemistry, colloidal gold, and HPLC technology platforms, Wondfo has developed a comprehensive primary care solution. The company also introduced an intelligent POCT management system, enabling real-time quality control, digitalized data management, and visualization. These innovations support primary healthcare institutions in chronic disease management, infectious disease prevention, maternal and child health, cancer screening, and public health monitoring.


 

Emergency & Critical Care Solutions
 
Wondfo also introduced a comprehensive and flexible emergency & critical care solution based on new-generation fluorescence immunoassay, chemiluminescence, and electrochemistry platforms. Designed for rapid testing, simplified operation, and immediate application, this solution supports emergency patient triage, critical condition monitoring, and comprehensive assessment of severe cases.
 


Pathology Solutions
 
Wondfo’s pathology solution integrates fully automated staining platforms and digital slide scanners, expanding pathology applications across multiple areas. The solution provides staining, scanning, and AI-powered analysis, enhancing disease diagnosis, treatment, and preventions for patients.
 


Recognizing Excellence & Fostering Long-term Collaboration
 
With over 30 years of expertise in in-vitro diagnostics, Wondfo remains committed to driving global healthcare innovation through strong partnerships. To honor the contributions of outstanding partners, the conference concluded with a special awards ceremony and gala dinner, celebrating those who have helped advance healthcare worldwide.
 

Racing for Life, Wondfo remains at the forefront of scientific research and innovation, working hand in hand with global partners to accelerate the adoption of faster, more precise, and more comprehensive diagnostic solutions, make biotechnology benefit all.